Absci (ABSI) EBITDA (2020 - 2026)
Absci (ABSI) reported EBITDA of -$30.8 million for Q1 2026, down 11.24% on a YoY basis from -$34.8 million in Q1 2025, and up 0.63% sequentially from -$31.0 million in Q4 2025.
Absci (ABSI) EBITDA (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of EBITDA data on file, last reported at -$30.8 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 11.24% year-over-year to -$30.8 million; the trailing twelve-month figure through Mar 2026 stood at -$123.4 million (down 9.12% YoY), and the FY2025 full-year result was -$120.3 million, down 10.5% from the prior year.
- EBITDA grew to -$30.8 million in Q1 2026, from -$31.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$21.1 million in Q4 2022 to a low of -$43.0 million in Q2 2023.
- A 5-year average of -$28.4 million and a median of -$28.8 million in 2022 frame the typical range for EBITDA.
- Across the five-year window, EBITDA sank 158.37% in 2022 and soared 37.84% in 2024, its largest moves.
- Tracing ABSI's EBITDA over 5 years: stood at -$21.1 million in 2022, then declined by 17.29% to -$24.7 million in 2023, then dropped by 20.35% to -$29.8 million in 2024, then decreased by 4.26% to -$31.0 million in 2025, then gained by 0.63% to -$30.8 million in 2026.
- Business Quant data shows ABSI's EBITDA at -$30.8 million in Q1 2026, -$31.0 million in Q4 2025, and -$30.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -30.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.85 Mn |
| Dec 31, 2025 | -31.04 Mn |
| Sep 30, 2025 | -30.15 Mn |
| Jun 30, 2025 | -31.39 Mn |
| Mar 31, 2025 | -27.73 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Sep 30, 2024 | -28.90 Mn |
| Jun 30, 2024 | -26.72 Mn |
| Mar 31, 2024 | -23.50 Mn |
| Dec 31, 2023 | -24.74 Mn |
| Sep 30, 2023 | -23.30 Mn |
| Jun 30, 2023 | -42.99 Mn |
| Mar 31, 2023 | -24.49 Mn |
| Dec 31, 2022 | -21.09 Mn |
| Sep 30, 2022 | -27.97 Mn |
| Jun 30, 2022 | -28.89 Mn |
| Mar 31, 2022 | -28.80 Mn |
| Dec 31, 2021 | -26.26 Mn |
| Sep 30, 2021 | -21.14 Mn |
| Jun 30, 2021 | -16.69 Mn |